228 related articles for article (PubMed ID: 35020534)
1. Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection.
Wang R; Hume AJ; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Le Suer J; Huang J; Olejnik J; Villacorta-Martin C; Bullitt E; Hinds A; Ghaedi M; Rollins S; Werder RB; Abo KM; Wilson AA; Mühlberger E; Kotton DN; Hawkins FJ
Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L462-L478. PubMed ID: 35020534
[TBL] [Abstract][Full Text] [Related]
2. Effective SARS-CoV-2 replication of monolayers of intestinal epithelial cells differentiated from human induced pluripotent stem cells.
Minami S; Matsumoto N; Omori H; Nakamura Y; Tamiya S; Nouda R; Nurdin JA; Yamasaki M; Kotaki T; Kanai Y; Okamoto T; Tachibana T; Ushijima H; Kobayashi T; Sato S
Sci Rep; 2023 Jul; 13(1):11610. PubMed ID: 37463955
[TBL] [Abstract][Full Text] [Related]
3. Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids.
Tiwari SK; Wang S; Smith D; Carlin AF; Rana TM
Stem Cell Reports; 2021 Mar; 16(3):437-445. PubMed ID: 33631122
[TBL] [Abstract][Full Text] [Related]
4. Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids.
Tsai PH; Sun JR; Chien Y; Chan MS; Khor W; Yang HC; Huang CH; Hsiung CN; Hwa TY; Lin YY; Yeh CL; Wang ML; Yang YP; Chen YM; Tsai FT; Lee MS; Cheng YH; Tsai SK; Liu PC; Chou SJ; Chiou SH
J Adv Res; 2024 Jun; 60():127-140. PubMed ID: 37557954
[TBL] [Abstract][Full Text] [Related]
5. Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation.
Higashi-Kuwata N; Yabe SG; Fukuda S; Nishida J; Tamura-Nakano M; Hattori SI; Okochi H; Mitsuya H
Microbiol Spectr; 2022 Dec; 10(6):e0349022. PubMed ID: 36314907
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
[TBL] [Abstract][Full Text] [Related]
7. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
8. Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factors.
Abo KM; Ma L; Matte T; Huang J; Alysandratos KD; Werder RB; Mithal A; Beermann ML; Lindstrom-Vautrin J; Mostoslavsky G; Ikonomou L; Kotton DN; Hawkins F; Wilson A; Villacorta-Martin C
bioRxiv; 2020 Jun; ():. PubMed ID: 32577635
[TBL] [Abstract][Full Text] [Related]
9. Topical TMPRSS2 inhibition prevents SARS-CoV-2 infection in differentiated human airway cultures.
Guo W; Porter LM; Crozier TW; Coates M; Jha A; McKie M; Nathan JA; Lehner PJ; Greenwood EJ; McCaughan F
Life Sci Alliance; 2022 Apr; 5(4):. PubMed ID: 35110354
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
Huang J; Hume AJ; Abo KM; Werder RB; Villacorta-Martin C; Alysandratos KD; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Olejnik J; Suder EL; Bullitt E; Hinds A; Sharma A; Bosmann M; Wang R; Hawkins F; Burks EJ; Saeed M; Wilson AA; Mühlberger E; Kotton DN
Cell Stem Cell; 2020 Dec; 27(6):962-973.e7. PubMed ID: 32979316
[TBL] [Abstract][Full Text] [Related]
11. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium.
Yamada S; Noda T; Okabe K; Yanagida S; Nishida M; Kanda Y
J Pharmacol Sci; 2022 Jul; 149(3):139-146. PubMed ID: 35641026
[TBL] [Abstract][Full Text] [Related]
13. Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing.
Tsuji K; Yamada S; Hirai K; Asakura H; Kanda Y
J Toxicol Sci; 2021; 46(9):425-435. PubMed ID: 34470994
[TBL] [Abstract][Full Text] [Related]
14. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
[TBL] [Abstract][Full Text] [Related]
15. Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease.
Osan J; Talukdar SN; Feldmann F; DeMontigny BA; Jerome K; Bailey KL; Feldmann H; Mehedi M
Microbiol Spectr; 2022 Aug; 10(4):e0045922. PubMed ID: 35862971
[TBL] [Abstract][Full Text] [Related]
16. Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs.
Wu T; Rabi SA; Michaud WA; Becerra D; Gilpin SE; Mino-Kenudson M; Ott HC
Biomaterials; 2022 Jun; 285():121509. PubMed ID: 35533440
[TBL] [Abstract][Full Text] [Related]
17. Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes.
Lee CY; Huang CH; Rastegari E; Rengganaten V; Liu PC; Tsai PH; Chin YF; Wu JR; Chiou SH; Teng YC; Lee CW; Liang Y; Chen AY; Hsu SC; Hung YJ; Sun JR; Chien CS; Chien Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576032
[TBL] [Abstract][Full Text] [Related]
18. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
Kimura H; Francisco D; Conway M; Martinez FD; Vercelli D; Polverino F; Billheimer D; Kraft M
J Allergy Clin Immunol; 2020 Jul; 146(1):80-88.e8. PubMed ID: 32422146
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia.
Chen R; Hui KP; Liang Y; Ng KC; Nicholls JM; Ip MS; Peiris M; Chan MC; Mak JC
Virol J; 2023 Apr; 20(1):65. PubMed ID: 37041586
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
